Skip to content

Viral Respiratory and Gastrointestinal Infections in Children Under 6 Years of Age

Viral Respiratory and Gastrointestinal Infections in Children Under 6 Years of Age - the Clinical Relevance of Newly Discovered Viruses

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00987519
Enrollment
1260
Registered
2009-10-01
Start date
2009-10-31
Completion date
2010-10-31
Last updated
2010-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis, Convulsion, Febrile, Gastroenteritis

Keywords

acute bronchiolitis, acute gastroenteritis, febrile convulsion, viral agents, molecular methods

Brief summary

With the use of molecular methods new viruses have been detected in respiratory and gastrointestinal tracts of both patients and asymptomatic subjects in recent years. The clinical importance of these viruses has not been adequately studied. The aim of this study is to use molecular methods to detect viruses in upper respiratory tract and gastrointestinal tract of children with acute bronchiolitis, acute gastroenteritis and febrile convulsions and to try to correlate the severity of clinical picture with the amount of viruses present in clinical samples. The investigators will also try to detect the increase in specific antibodies in paired sera.

Interventions

None listed

Sponsors

University of Ljubljana School of Medicine, Slovenia
CollaboratorOTHER
University Medical Centre Ljubljana
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 5 Years
Healthy volunteers
Yes

Inclusion criteria

presence of * acute bronchiolitis * acute gastroenteritis * febrile convulsion requiring hospital admission

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frame
To describe the clinical picture of a viral respiratory and/or gastrointestinal infection associated with a specific viral pathogenIn a 14-day period

Secondary

MeasureTime frame
To correlate the severity of clinical picture with the quantity of virus in clinical samplesIn a 14-day period

Countries

Slovenia

Contacts

Primary ContactMarko Pokorn, MD, MSc
marko.pokorn@mf.uni-lj.si+38641712241
Backup ContactTatjana Mrvič, MD, MSc
tatjana.mrvic@guest.arnes.si+38615222110

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026